Recombinant Human SAA4 Protein，His

SAA4, or Serum Amyloid A4, is a protein that belongs to the serum amyloid A (SAA) family, which plays a critical role in the acute phase response to inflammation. This protein is primarily produced by the liver and is involved in various physiological processes, including lipid metabolism, immune response, and tissue repair. The SAA proteins, particularly SAA1 and SAA2, have been extensively studied due to their association with inflammatory diseases and amyloidosis. However, SAA4 has garnered attention as its function and clinical relevance remain less understood. Recent research has indicated that SAA4 may have protective roles in certain inflammatory conditions, and its expression patterns can vary in different tissues and disease states. Understanding the molecular mechanisms and biological pathways involving SAA4 could provide insights into its potential role in inflammatory diseases, cardiovascular health, and potential therapeutic applications. Moreover, the development of recombinant SAA4 protein may facilitate further studies to elucidate its functional properties and interactions within the immune system, potentially leading to novel biomarker development and therapeutic strategies targeting inflammation-related disorders. Overall, exploring SAA4's biochemical characteristics and functional implications is crucial for advancing our understanding of its impact on human health and disease.